51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 525 / 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03717961 (ClinicalTrials.gov)	October 15, 2018	15/10/2018	Efficacy of Botulinum Toxin Ain Adult Subjects With Raynaud Phenomenon Secondary to Systemic Scleros ...	Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Study to Assess Efficacy ...	Raynaud Phenomenon Secondary to Systemic Sclerosis	Drug: BOTOX ® solution;Drug: Placebo group	Assistance Publique - Hôpitaux de Paris	NULL	Completed	18 Years	N/A	All	91	Phase 3	France
2	JPRN-UMIN000017617	2014/11/01	19/05/2015	Effect of botulinum toxin A on Raynaud's phenomenon in patients with systemic sclerosis	Effect of botulinum toxin Aon Raynaud's phenomenon in patients with systemic sclerosis - BTX-A on Ra ...	Raynaud's phenomenon	Botulinum toxin A injection	Gunma University Hospital	NULL	Complete: follow-up complete	18years-old	Not applicable	Male and Female	10	Not selected	Japan

First Previous1Next Last